Literature DB >> 10325233

Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death.

G A Pestano1, Y Zhou, L A Trimble, J Daley, G F Weber, H Cantor.   

Abstract

Misselected CD8 cells that express T cell receptors (TCRs) that do not recognize class I major histocompatibility complex (MHC) protein can emerge from thymic selection. A postthymic quality control mechanism that purges these cells from the repertoire is defined here. The failure of mature CD8 cells to simultaneously engage their TCR and CD8 coreceptor triggers an activation process that begins with inhibition of CD8 gene expression through remethylation and concludes with up-regulation of surface Fas and Fas ligand and cellular apoptosis. Thus, inhibition of a death signal through continued TCR-CD8 coengagement of MHC molecules is a key checkpoint for the continued survival of correctly selected T cells. Molecular defects that prevent delivery of the death signal to mistakenly selected T cells underlie the expansion of double-negative T cells, which is the cellular signature of a subset of systemic autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325233     DOI: 10.1126/science.284.5417.1187

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  20 in total

Review 1.  The role of CD4 in regulating homeostasis of T helper cells.

Authors:  Rolf König; Xiaoli Shen; Rosario Maroto; Timothy L Denning
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Reversal of established autoimmune diabetes by restoration of endogenous beta cell function.

Authors:  S Ryu; S Kodama; K Ryu; D A Schoenfeld; D L Faustman
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

3.  Detailed analysis of gene expression during development of T cell lineages in the thymus.

Authors:  Nami McCarty; Mari L Shinohara; Linrong Lu; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-09       Impact factor: 11.205

4.  Cutting edge: Lymphoproliferation caused by Fas deficiency is dependent on the transcription factor eomesodermin.

Authors:  Ichiko Kinjyo; Scott M Gordon; Andrew M Intlekofer; Kennichi Dowdell; Erin C Mooney; Roberto Caricchio; Stephan A Grupp; David T Teachey; V Koneti Rao; Tullia Lindsten; Steven L Reiner
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

5.  Programmed cell death 1 and Helios distinguish TCR-αβ+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells.

Authors:  Noé Rodríguez-Rodríguez; Sokratis A Apostolidis; Pablo Penaloza-MacMaster; José Manuel Martín Villa; Dan H Barouch; George C Tsokos; José C Crispín
Journal:  J Immunol       Date:  2015-03-30       Impact factor: 5.422

6.  Differential roles of osteopontin/Eta-1 in early and late lpr disease.

Authors:  G F Weber; H Cantor
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

7.  Tolerance induction and endogenous regeneration of pancreatic beta-cells in established autoimmune diabetes.

Authors:  Charles Sia; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2005-02-10

8.  Interleukin-4-induced loss of CD8 expression and cytolytic function in effector CD8 T cells persists long term in vivo.

Authors:  Stuart Olver; Simon H Apte; Adriana Baz; Anne Kelso; Norbert Kienzle
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

9.  Pro-inflammatory self-reactive T cells are found within murine TCR-αβ(+) CD4(-) CD8(-) PD-1(+) cells.

Authors:  Noé Rodríguez-Rodríguez; Sokratis A Apostolidis; Lauren Fitzgerald; Bronwyn S Meehan; Alexandra J Corbett; José Manuel Martín-Villa; James McCluskey; George C Tsokos; José C Crispín
Journal:  Eur J Immunol       Date:  2016-04-26       Impact factor: 5.532

10.  Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.

Authors:  Abdiaziz S Mohamood; Mehmet L Guler; Zuoxiang Xiao; Dongfeng Zheng; Allan Hess; Yi Wang; Hideo Yagita; Jonathan P Schneck; Abdel Rahim A Hamad
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.